Display options
Share it on

Front Immunol. 2017 Jul 28;8:835. doi: 10.3389/fimmu.2017.00835. eCollection 2017.

Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis.

Frontiers in immunology

Gayane Harutyunyan, Larissa Hauer, Martin W Dünser, Tobias Moser, Slaven Pikija, Markus Leitinger, Helmut F Novak, Wolfgang Aichhorn, Eugen Trinka, Johann Sellner

Affiliations

  1. Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria.
  2. Department of Psychiatry and Psychotherapy, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria.
  3. Department of Critical Care, University College of London Hospital, London, United Kingdom.
  4. Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany.

PMID: 28804482 PMCID: PMC5532517 DOI: 10.3389/fimmu.2017.00835

Abstract

BACKGROUND: Prevention and early recognition of critical illness in patients with autoimmune encephalitis (AE) is essential to achieve better outcome.

AIM OF THE STUDY: To evaluate risk factors for intensive care unit (ICU) admission and its prognostic impact in patients with AE.

PATIENTS AND METHODS: A reclassification of patients hospitalized between 2011 and 2016 revealed 17 "definite" and 15 "probable" AE cases. Thirteen patients (41%) developed critical illness and required ICU admission. The underlying conditions were intractable seizures or status epilepticus (54%), altered mental state (39%), and respiratory failure (8%).

RESULTS: ICU admission was associated with longer time from first symptoms to hospitalization (

CONCLUSION: We confirmed the need for ICU care in a subgroup of patients and the prevailing objective is improved seizure control, and definite diagnosis of AE and anemia were identified as risk factors for development of critical illness. However, prognosis was not affected by ICU admission.

Keywords: autoimmune encephalitis; critical care; humoral immunity; neurodegeneration; prognosis; seizures

References

  1. Front Psychiatry. 2017 Feb 16;8:25 - PubMed
  2. Acta Neurol Scand. 2016 Dec 27;:null - PubMed
  3. Lancet Neurol. 2013 Feb;12(2):157-65 - PubMed
  4. J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):748-55 - PubMed
  5. Am J Respir Crit Care Med. 2012 May 15;185(10):1049-57 - PubMed
  6. Brain. 2004 Mar;127(Pt 3):701-12 - PubMed
  7. Neurocrit Care. 2017 Aug;27(1):82-89 - PubMed
  8. Neurocrit Care. 2016 Apr;24(2):240-50 - PubMed
  9. Lancet Neurol. 2008 Dec;7(12):1091-8 - PubMed
  10. Neurol Sci. 2016 Dec;37(12 ):1993-1998 - PubMed
  11. Heart Lung. 2010 May-Jun;39(3):217-25 - PubMed
  12. Neurology. 2015 Jan 27;84(4):359-66 - PubMed
  13. J Clin Neurol. 2016 Jan;12(1):1-13 - PubMed
  14. Eur J Neurol. 2015 Jan;22(1):6-16, e1 - PubMed
  15. J Neurosci Methods. 2016 Feb 15;260:252-60 - PubMed
  16. Neurohospitalist. 2013 Apr;3(2):53-64 - PubMed
  17. Neurologist. 2017 Jan;22(1):1-13 - PubMed
  18. Lancet Infect Dis. 2010 Dec;10(12):835-44 - PubMed
  19. Anaesth Intensive Care. 2010 Jul;38(4):748-50 - PubMed
  20. Acta Neurol Scand. 2017 Jan;135(1):134-141 - PubMed
  21. Clinics (Sao Paulo). 2007 Aug;62(4):507-24 - PubMed
  22. Am J Respir Crit Care Med. 2017 Feb 15;195(4):491-499 - PubMed
  23. Front Cell Neurosci. 2015 Oct 27;9:431 - PubMed
  24. Lancet Neurol. 2016 Apr;15(4):391-404 - PubMed
  25. J Clin Neurosci. 2014 May;21(5):722-30 - PubMed
  26. Clin Infect Dis. 2013 Oct;57(8):1114-28 - PubMed

Publication Types